Rifat Latifi1, Apar S Patel1, David J Samson2, Elizabeth H Tilley1, Saranda Gashi1, Roberto Bergamaschi1, Ayman El-Menyar3. 1. Department of Surgery, Westchester Medical Center and New York Medical College, Valhalla, NY, USA. 2. Department of Surgery, Westchester Medical Center and New York Medical College, Valhalla, NY, USA. david.samson@wmchealth.org. 3. Clinical Research, Trauma Surgery, Hamad General Hospital (HGH), Doha, Qatar.
Abstract
PURPOSE: Severe necrotizing soft-tissue infections (NSTIs) require immediate early surgical treatment to avoid adverse outcomes. This study aims to determine the impact of early surgery and comorbid conditions on the outcomes of NSTIs. METHODS: A retrospective cohort study was performed on all subjects presenting with NSTI at an academic medical center between 2005 and 2016. Patients were identified based on ICD codes. Those under the age of 18 or with intraoperative findings not consistent with NSTI diagnosis were excluded. RESULTS: There were 115 patients with a confirmed diagnosis of NSTI with a mean age of 55 ± 18 years; 41% were females and 55% were diabetics. Thirty percent of patients underwent early surgery (< 6 h). There were no significant differences between groups in baseline characteristics. The late group (≥ 6 h) had prolonged hospital stay (38 vs. 23 days, p < 0.008) in comparison to the early group (< 6 h). With every 1 h delay in time to surgery, there is a 0.268 day increase in length of stay, adjusted for these other variables: alcohol abuse, number of debridements, peripheral vascular disease, previous infection and clinical necrosis. Mortality was 16.5%. Multivariable analysis revealed that alcohol abuse, peripheral vascular disease, diabetes, obesity, hypothyroidism, and presence of COPD were associated with an increase in mortality. CONCLUSIONS: Early surgical intervention in patients with severe necrotizing soft-tissue infections reduces length of hospital stay. Presence of comorbid conditions such as alcohol abuse, peripheral vascular disease, diabetes, obesity and hypothyroidism were associated with increased mortality.
PURPOSE: Severe necrotizing soft-tissue infections (NSTIs) require immediate early surgical treatment to avoid adverse outcomes. This study aims to determine the impact of early surgery and comorbid conditions on the outcomes of NSTIs. METHODS: A retrospective cohort study was performed on all subjects presenting with NSTI at an academic medical center between 2005 and 2016. Patients were identified based on ICD codes. Those under the age of 18 or with intraoperative findings not consistent with NSTI diagnosis were excluded. RESULTS: There were 115 patients with a confirmed diagnosis of NSTI with a mean age of 55 ± 18 years; 41% were females and 55% were diabetics. Thirty percent of patients underwent early surgery (< 6 h). There were no significant differences between groups in baseline characteristics. The late group (≥ 6 h) had prolonged hospital stay (38 vs. 23 days, p < 0.008) in comparison to the early group (< 6 h). With every 1 h delay in time to surgery, there is a 0.268 day increase in length of stay, adjusted for these other variables: alcohol abuse, number of debridements, peripheral vascular disease, previous infection and clinical necrosis. Mortality was 16.5%. Multivariable analysis revealed that alcohol abuse, peripheral vascular disease, diabetes, obesity, hypothyroidism, and presence of COPD were associated with an increase in mortality. CONCLUSIONS: Early surgical intervention in patients with severe necrotizing soft-tissue infections reduces length of hospital stay. Presence of comorbid conditions such as alcohol abuse, peripheral vascular disease, diabetes, obesity and hypothyroidism were associated with increased mortality.
Entities:
Keywords:
Alcohol abuse; Hospital length of stay; Mortality; Necrotizing soft-tissue infection; Peripheral vascular disease; Renal insufficiency/failure; Time to surgery
Authors: Daniel N Holena; Angela M Mills; Brendan G Carr; Chris Wirtalla; Babak Sarani; Patrick K Kim; Benjamin M Braslow; Rachel R Kelz Journal: Surgery Date: 2011-07-23 Impact factor: 3.982
Authors: Femke Nawijn; Diederik P J Smeeing; Roderick M Houwert; Luke P H Leenen; Falco Hietbrink Journal: World J Emerg Surg Date: 2020-01-08 Impact factor: 5.469
Authors: Markus Korsholm Kristensen; Marco Bo Hansen; Martin Bruun Madsen; Cecilie Bo Hansen; Katrine Pilely; Ole Hyldegaard; Peter Garred Journal: Front Immunol Date: 2020-01-31 Impact factor: 7.561
Authors: Maximilian Leiblein; Nils Wagner; Elisabeth H Adam; Johannes Frank; Ingo Marzi; Christoph Nau Journal: Orthop Surg Date: 2020-10-04 Impact factor: 2.071